14 October 2021

VEROVACCiNES closes Series B financing with consortium of investors from Germany and Switzerland

  • Vaccine specialist closes Mid-Seven-Figure Series B Financing Round
  • Shareholder group expanded by four new investors with important expertise
  • The fresh funding will be used to drive several vaccine programs into regulatory development
  •